Do I qualify?

What is PAD?

What is PAD?Peripheral Arterial Disease (PAD)

A condition which affects approximately 12 million Americans. It occurs when blood vessels become narrowed or locked by plaque, which decreases the blood flow to the area. 

PAD can develop in other areas of the body, but is commonly found in the legs, feet and toes. If left untreated, it can cause severe leg pain and lead to critical limb ischemia.

Critical Limb Ischemia (CLI):

PAD can progress to critical limb ischemia, which means there is not enough blood being delievered to the leg to keep the tissue alive. 

An estimated 1.5-2 million people in the United States suffer from CLI, and are at risk of amputation of the toes, feet, and legs.

   Click here for more information on CLI

 

New Study:

Sign-up for the studyDo you have Peripheral Arterial Disease (PAD)?

Do you have a sore on your leg, ankle, or foot that will not heal?

Have you been diagnosed with Critical Limb Ischemia?

 


You may qualify to participate in a study of an investigational treatment for patients with PAD and non-healing wounds if you are between 18-75 years old with a diagnosis of critical limb ischemia.

This study seeks to determine if treatment with adult stem cells, taken from the patient’s own bone marrow, can improve healing and prevent amputation.

This study is being conducted at two locations; Kansas City Vascular, Kansas City, Missouri by Dr. Karl Stark. The title of the study is: Single-center randomized double-blind placebo-controlled phase 2 proof of concept study to assess the efficacy and safety of ASCT01 in Patients with Critical Limb Ischemia, Sponsored by Lifecells LLC.

 

Sign up for Participation
  1. This Clinical Trial is for Rutherford Stage 4 and 5 Peripheral Arterial Disease patients with non-healing wounds, between 18 and 80 years old with a diagnosis of Critical Limb Ischemia.

    The study seeks to determine if treatment with adult stem cells, taken from the patient’s own bone marrow, can improve healing and prevent amputation. This study is being conducted at two locations; Kansas City Vascular, Kansas City, Missouri by Dr. Karl Stark and at the University of Kansas Medical Center by Dr. Buddhadeb Dawn.

    Participants will undergo a screening process to see if they qualify. Qualified subjects will spend 1- to 2 days in the hospital during the initial study period and will have an additional 5 outpatient visits over the following year. All study procedures will be provided at no cost.

    If you qualify or know a patient that may qualify, please use the form below to contact us.
  2. Full Name(*)
    Please enter your full name.
  3. Email(*)
    Please enter a valid email address
  4. Phone(*)
    Please enter a valid phone number
  5. City(*)
    Please enter the city where you currently live.
  6. State(*)
    Please enter the state where you currently live.
  7. Category of PAD/CLI(*)


    Please specify your position in the company
  8. Patient, Referral(*)



    Please select the type of contact
  9. Vascular doctor's Name
    Please do not use special characters.
  10. Dr.'s Phone Number
    Please enter valid phone number
  11. May we call doctor?
    Invalid Input
  12. How should we contact you?(*)


  13.   

Contact Us       |        See if You Qualify        |        Sign Up for Participation        |        Study Information